NanoViricides
NNVC
#10098
Rank
A$36.22 M
Marketcap
A$2.01
Share price
8.94%
Change (1 day)
-13.40%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): A-$0.93

According to NanoViricides's latest financial reports the company's current EPS (TTM) is A-$0.92. In 2024 the company made an earnings per share (EPS) of A-$1.05 an increase over its 2023 EPS that were of A-$1.11.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.93-11.25%
2024A-$1.05-5.41%
2023A-$1.115.71%
2022A-$1.05-13.58%
2021A-$1.22-66.11%
2020A-$3.591.7%
2019A-$3.53-10.98%
2018A-$3.97-22.35%
2017A-$5.11-10.53%
2016A-$5.71375%
2015A-$1.20-85.19%
2014A-$8.1142.11%
2013A-$5.7126.67%
2012A-$4.51-6.25%
2011A-$4.8114.28%
2010A-$4.21100%
2009A-$2.10-0%
2008A-$2.10-33.33%
2007A-$3.15-0%
2006A-$3.154445.07%
2005A-$0.06941

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
A-$0.07511-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$3.18-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.79-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.46-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.41-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.40-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK